In contrast, Kattner et al. [26] focused on the role of serum Krebs von den Lungen-6 (KL-6) in predicting outcomes in 157 patients with SARS-CoV-2 pneumonia, finding that a cut-off of 335 U/mL was a significant predictor of severe disease outcomes. Here, MUC1 is linked to severe acute respiratory syndrome.